BRIVIACT (brivaracetam)* tablets, for oral use, CV

BRIVIACT (brivaracetam)* oral solution, CV

BRIVIACT (brivaracetam)* injection, for intravenous use, CV

UCB

• BRIVIACT is indicated for the treatment of partial-onset seizures in patients 1 month of age and older.

• Store at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). See USP Controlled Room Temperature.
• Do not freeze BRIVIACT injection or oral solution.
• Discard any unused BRIVIACT oral solution remaining after 5 months of first opening the bottle.
• BRIVIACT injection vials are single-dose only

*BRIVIACT contains brivaracetam and is listed as a Schedule V controlled substance.